IONIS PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of ISI for the last quarter is 107.80 M CHF, and it's 60.60% lower compared to the previous quarter. The net income of Q1 24 is -128.83 M CHF.